Intellia Therapeutics Announces Fourth Quarter and Full-Year 2024 Financial Results and Highlights Recent Company ProgressGlobeNewsWire • 02/27/25
Robbins LLP Reminds Intellia Therapeutics, Inc. (NTLA) Investors with Large Losses to Contact the Firm to Learn How They Can Recover for Their LossesPRNewsWire • 02/27/25
Shareholders of Intellia Therapeutics, Inc. Should Contact The Gross Law Firm Before April 14, 2025 to Discuss Your Rights – NTLAGlobeNewsWire • 02/26/25
2 Beaten-Down Stocks to Buy Before They Soar by 66% and 415%, According to Wall StreetThe Motley Fool • 02/24/25
Intellia Therapeutics, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - NTLAPRNewsWire • 02/24/25
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Intellia Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - NTLAAccesswire • 02/21/25
Intellia Therapeutics, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before April 14, 2025 to Discuss Your Rights – NTLAGlobeNewsWire • 02/21/25
A Lawsuit Has Been Filed Against Intellia Therapeutics, Inc. For Securities Law Violations And Investors With Losses Are Urged To Contact The Schall Law FirmAccesswire • 02/21/25
NTLA Investors are Suing Intellia Therapeutics, Inc.; Contact Robbins LLP for More InformationGlobeNewsWire • 02/20/25
Class Action Filed Against Intellia Therapeutics, Inc. (NTLA) - April 14, 2025 Deadline to Join – Contact The Gross Law FirmGlobeNewsWire • 02/20/25
Intellia Therapeutics, Inc. (NTLA) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 ReleaseZacks Investment Research • 02/20/25
Intellia Therapeutics (NTLA) Stock Jumps 6.5%: Will It Continue to Soar?Zacks Investment Research • 02/20/25
Intellia Therapeutics to Hold Conference Call to Discuss Fourth Quarter and Full-Year 2024 Earnings and Company UpdatesGlobeNewsWire • 02/20/25
The Gross Law Firm Notifies Shareholders of Intellia Therapeutics, Inc.(NTLA) of a Class Action Lawsuit and an Upcoming DeadlinePRNewsWire • 02/20/25
Intellia Therapeutics, Inc. Is Being Sued For Securities Law Violations And Investors With Losses Are Urged To Contact The Schall Law FirmAccesswire • 02/19/25
ROSEN, A TOP RANKED LAW FIRM, Encourages Intellia Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - NTLAAccesswire • 02/18/25
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of April 14, 2025 in Intellia Lawsuit -– NTLAAccesswire • 02/16/25
ROSEN, GLOBALLY RECOGNIZED INVESTOR COUNSEL, Encourages Intellia Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – NTLAGlobeNewsWire • 02/16/25
INTELLIA ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Intellia Therapeutics, Inc. and Encourages Investors to Contact the FirmGlobeNewsWire • 02/15/25
Does Intellia Therapeutics (NTLA) Have the Potential to Rally 422.41% as Wall Street Analysts Expect?Zacks Investment Research • 02/14/25
Rosen Law Firm Urges Intellia Therapeutics, Inc. (NASDAQ: NTLA) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their RightsBusiness Wire • 02/13/25
Investor Alert: Robbins LLP Informs Stockholders of the Intellia Therapeutics, Inc. Class ActionPRNewsWire • 02/13/25
INTELLIA THERAPEUTICS, INC. (NASDAQ: NTLA) INVESTOR ALERT: Investors With Large Losses in Intellia Therapeutics, Inc. Should Contact Bernstein Liebhard LLP To Discuss Their RightsGlobeNewsWire • 02/12/25